Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Manufacturing

BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot

 April 3, 2026

BioSpace

BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology continues to face headwinds in the U.S.

ManufacturingRead full story

Post navigation

US pharma tariffs of up to 100% finalised by Trump →
← Trump revives pharma tariffs with 100% charges, but leaves loopholes

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com